Comparison of drug prescribing before and during the COVID ‐19 pandemic: A cross‐national European study

Author:

Selke Krulichová Iva1ORCID,Selke Gisbert W.2ORCID,Bennie Marion34ORCID,Hajiebrahimi Mohammadhossein5ORCID,Nyberg Fredrik6ORCID,Fürst Jurij7,Garuolienė Kristina8ORCID,Poluzzi Elisabetta9ORCID,Slabý Juraj10,Yahni Corinne Zara11ORCID,Altini Mattia12ORCID,Fantini Maria Pia9ORCID,Kočí Václav10,McTaggart Stuart4ORCID,Pontes Caridad1113ORCID,Reno Chiara9ORCID,Rosa Simona9,Pedrola Marta Turu11ORCID,Udovič Mitja7,Wettermark Björn514ORCID

Affiliation:

1. Department of Medical Biophysics, Faculty of Medicine in Hradec Králové Charles University Hradec Králové Czech Republic

2. Pharmaceuticals Information Systems and Analyses AOK Research Institute (WIdO) Berlin Germany

3. Strathclyde Institute of Pharmacy and Biomedical Sciences University of Strathclyde Glasgow UK

4. Public Health and Intelligence Public Health Scotland Edinburgh UK

5. Department of Pharmacy Uppsala University Uppsala Sweden

6. School of Public Health and Community Medicine, Sahlgrenska Academy University of Gothenburg Göteborg Sweden

7. Department of Medicinal Products Health Insurance Institute of Slovenia Ljubljana Slovenia

8. Department of Pathology, Forensic Medicine and Pharmacology, Institute of Biomedical Sciences, Faculty of Medicine Vilnius University Vilnius Lithuania

9. Department of Biomedical and Neuromotor Sciences Alma Mater Studiorum – University of Bologna Bologna Italy

10. Section of Pricing and Reimbursement Regulation State Institute for Drug Control Praha Czech Republic

11. Drug Department Catalan Health Service Barcelona Spain

12. Healthcare Administration Azienda Unità Sanitaria Locale della Romagna Ravenna Italy

13. Department of Pharmacology, Therapeutics and Toxicology Universitat Autònoma de Barcelona Barcelona Spain

14. Pharmacy Center, Faculty of Medicine Vilnius University Vilnius Lithuania

Funder

NordForsk

Univerzita Karlova v Praze

Stockholms Läns Landsting

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3